ElectroCore Overview
- Year Founded
-
2005
- Status
-
Public
- Employees
-
83
- Stock Symbol
-
ECOR
- Investments
-
1
- Share Price
-
$4.88
- (As of Monday Closing)
ElectroCore General Information
Description
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.
Contact Information
Website
www.electrocore.comCorporate Office
- 200 Forge Way
- Suite 205
- Rockaway, NJ 07866
- United States
Corporate Office
- 200 Forge Way
- Suite 205
- Rockaway, NJ 07866
- United States
ElectroCore Timeline
ElectroCore Stock Performance
As of 16-Nov-2026, ElectroCore’s stock price is $4.88. Its current market cap is $44.7M with 9.2M shares.
(As of Monday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $4.88 | $5.25 | $4.37 - $12.70 | $44.7M | 9.2M | 105K | -$1.36 |
ElectroCore Financials Summary
As of 30-Sep-2026, ElectroCore has a trailing 12-month revenue of $38M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 97,071 | 33,720 | 97,344 | 22,911 |
| Revenue | 37,967 | 32,032 | 25,182 | 16,030 |
| EBITDA | (11,078) | (11,996) | (10,904) | (18,428) |
| Net Income | (12,704) | (13,966) | (11,886) | (18,834) |
| Total Assets | 17,258 | 18,667 | 20,471 | 16,102 |
| Total Debt | 9,686 | 9,403 | 4,136 | 626 |
ElectroCore Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
ElectroCore Comparisons
Industry
Financing
Details
ElectroCore Competitors (6)
One of ElectroCore’s 6 competitors is NeuroMetrix, a Formerly VC-backed company based in Woburn, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| NeuroMetrix | Formerly VC-backed | Woburn, MA | ||||
| Alpha-Stim | Private Equity-Backed | Mineral Wells, TX | ||||
| Curonix | Private Equity-Backed | Pompano Beach, FL | ||||
| Aspen Medical Products | Private Equity-Backed | Irvine, CA | ||||
| Mainstay Medical | Venture Capital-Backed | San Diego, CA |
ElectroCore Patents
ElectroCore Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260083960-A1 | Devices for nerve stimulation | Pending | 26-Sep-2024 | ||
| US-20260069863-A1 | Devices for nerve stimulation | Pending | 06-Sep-2024 | ||
| US-20260061154-A1 | Systems and methods for nerve stimulation | Pending | 05-Sep-2024 | ||
| US-20250152939-A1 | Systems and methods for promoting general wellness | Pending | 15-Nov-2023 | ||
| US-20250099753-A1 | Wearable treatment device for non-invasive nerve stimulation | Pending | 22-Sep-2023 | A61N1/0496 |
ElectroCore Signals
ElectroCore Acquisitions (1)
ElectroCore’s most recent deal was a Merger/Acquisition with NeuroMetrix. The deal was made on 01-May-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| NeuroMetrix | 01-May-2025 | Merger/Acquisition | Therapeutic Devices |
ElectroCore ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
35.31 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,592
Rank
Percentile
Healthcare
Industry
of 590
Rank
Percentile
Medical Devices
Subindustry
of 209
Rank
Percentile
ElectroCore Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| NeuroMetrix | Woburn, MA | 1996 |
ElectroCore FAQs
-
When was ElectroCore founded?
ElectroCore was founded in 2005.
-
Where is ElectroCore headquartered?
ElectroCore is headquartered in Rockaway, NJ.
-
What is the size of ElectroCore?
ElectroCore has 83 total employees.
-
What industry is ElectroCore in?
ElectroCore’s primary industry is Therapeutic Devices.
-
Is ElectroCore a private or public company?
ElectroCore is a Public company.
-
What is ElectroCore’s stock symbol?
The ticker symbol for ElectroCore is ECOR.
-
What is the current stock price of ElectroCore?
As of 16-Nov-2026 the stock price of ElectroCore is $4.88.
-
What is the current market cap of ElectroCore?
The current market capitalization of ElectroCore is $44.7M.
-
What is ElectroCore’s current revenue?
The trailing twelve month revenue for ElectroCore is $38M.
-
Who are ElectroCore’s competitors?
NeuroMetrix, Alpha-Stim, Curonix, Aspen Medical Products, and Mainstay Medical are some of the 6 competitors of ElectroCore.
-
What is ElectroCore’s annual earnings per share (EPS)?
ElectroCore’s EPS for 12 months was -$1.36.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process